EUVIMEDEUVIMED felfedezése
Randomisierte kontrollierte Studie

Substance use outcomes from the Child/Adolescent Anxiety Multimodal Extended Long‐term Study (CAMELS)

Jonathan Rabner iD, Thomas M Olino iD, Anne Marie Albano, Courtney P Keeton, Dara Sakolsky, Boris Birmaher, John Piacentini, Tara S Peris, Scott N Compton, Elizabeth Gosch, Golda S Ginsburg, Elizabeth L Pinney and 1 more

Journal of Child Psychology and Psychiatry · 2024

DOI: 10.1111/jcpp.13926 ↗

At a glance

Randomisierte kontrollierte Studie in Journal of Child Psychology and Psychiatry, 2024. Written by Jonathan Rabner and 12 co-authors. Institution: Department of Psychology and Neuorscience, Temple University, Philadelphia, PA, USA. Major MEDLINE topics: Cognitive Behavioral Therapy, Substance-Related Disorders, Anxiety Disorders. Cited 2 times so far (Crossref); 47 references. Funded by: NIMH NIH HHS, Civic Foundation, National Institute of Mental Health.

AbsztraktSubjectsBibliográfiai adatokCiteRelated studies

Abstract (original language)

Background

Substance use problems and anxiety disorders are both highly prevalent and frequently cooccur in youth. The present study examined the benefits of successful anxiety treatment at 3–12 years after treatment completion on substance use outcomes (i.e. diagnoses and lifetime expected use).

Methods

The sample was from the Child/Adolescent Anxiety Multimodal Extended Long‐term Study (CAMELS), a naturalistic follow‐up study to the Child/Adolescent Anxiety Multimodal Study (CAMS) which randomized youth to cognitive behavioral therapy (CBT; Coping cat ), medication (sertraline), their combination, or pill placebo. The first CAMELS visit occurred an average of 6.5 years following CAMS randomization. Participants were 319 youth (65.4% of the CAMS sample), aged 7–17 years at CAMS baseline assessment with a mean age of 17.6 years (range: 11–26 years) at the time of the first CAMELS follow‐up. Substance use outcomes included diagnoses as well as lifetime substance use (i.e. alcohol and tobacco use).

Results

Eleven of 319 (3.4%) CAMELS participants were diagnosed with a substance use disorder at the initial follow‐up visit. When compared to the population lifetime rate of 11.4%, the rate of diagnoses in the posttreated sample was significantly lower. Additionally, rates of lifetime alcohol use were lower than population rates at the initial and final follow‐up visits. Rates of lifetime tobacco use were similarly lower than lifetime population rates at the initial visit (driven by significantly lower rates in the CBT treatment condition), but higher by the final visit. Furthermore, treatment remission (but not treatment response) was associated with a lower rate of substance use diagnoses at the initial follow‐up visit, although rates of lifetime alcohol and tobacco use did not differ by treatment outcome.

Conclusions

Anxiety treatments confer a beneficial impact on problematic substance use (i.e. diagnoses) as well as on expected substance use (i.e. alcohol and tobacco use) for on average, a period of 6.5 years.

Subjects

MeSH terms (MEDLINE)

Cognitive Behavioral TherapySubstance-Related DisordersAnxiety DisordersHumansAdolescentChildMaleFemaleCombined Modality TherapyFollow-Up StudiesSertralineYoung AdultAdultComorbidityOutcome Assessment, Health Care

Author keywords

Anxiety disorderscognitive behavioral therapysecondary preventionsubstance useyouth

Substances

Sertraline

Authors and institutions

  • Department of Psychology and Neuorscience, Temple University, Philadelphia, PA, USA.
  • Department of Psychiatry, New York State Psychiatric Institute, Columbia University Medical Center, New York, NY, USA.
  • Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.
  • Western Psychiatric Institute & Clinic, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
  • Department of Psychiatry and Biobehavioral Sciences, University of California Los Angeles School of Medicine, Los Angeles, CA, USA.

ORCID profiles: Jonathan Rabner, Thomas M Olino

Funding

  • NIMH NIH HHS
  • Civic Foundation
  • National Institute of Mental Health

Cite

APA

Rabner, J., Olino, T. M., Albano, A. M., Keeton, C. P., Sakolsky, D., Birmaher, B., Piacentini, J., Peris, T. S., Compton, S. N., Gosch, E., Ginsburg, G. S., Pinney, E. L., & Kendall, P. C. (2024). Substance use outcomes from the Child/Adolescent Anxiety Multimodal Extended Long‐term Study (CAMELS). Journal of Child Psychology and Psychiatry. https://doi.org/10.1111/jcpp.13926

Vancouver

Rabner J, Olino TM, Albano AM, Keeton CP, Sakolsky D, Birmaher B, et al. Substance use outcomes from the Child/Adolescent Anxiety Multimodal Extended Long‐term Study (CAMELS). Journal of Child Psychology and Psychiatry. 2024. doi:10.1111/jcpp.13926

BibTeX
@article{Rabner2024,
  author = {Rabner, Jonathan and Olino, Thomas M and Albano, Anne Marie and Keeton, Courtney P and Sakolsky, Dara and Birmaher, Boris and Piacentini, John and Peris, Tara S and Compton, Scott N and Gosch, Elizabeth and Ginsburg, Golda S and Pinney, Elizabeth L and Kendall, Philip C},
  title = {Substance use outcomes from the Child/Adolescent Anxiety Multimodal Extended Long‐term Study (CAMELS)},
  journal = {Journal of Child Psychology and Psychiatry},
  year = {2024},
  doi = {10.1111/jcpp.13926}
}
Start for free →